GLP-1 stimulates beta-cell mass expansion by activating proliferation and inhibiting apoptosis signaling pathways (Wang and Brubaker, 2002; Lee and Jun, 2014), and enhancing functional beta-cell mass is recently considered as a potential therapeutic target for diabetes (Chen et al., 2017). This evidence concerns the gene GLP1R and diabetes mellitus.